Norbixin, an apocarotenoid derivative activates PPARγ in cardiometabolic syndrome: Validation by in silico and in vivo experimental assessment

Norbixin, an apocarotenoid derivative activates PPARγ in cardiometabolic syndrome: Validation by in silico and in vivo experimental assessment

Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Life Sciences - Volume 209, 15 September 2018, Pages 69-77

Rohini A., Neeraj Agrawal, Harish Kumar, Virendra Nath, Vipin Kumar,